珍宝岛集团

Signed the strategic cooperation framework agreement with Hangzhou AnRun Pharmaceutical;

Strategic Cooperation Framework Agreement

Fufangqinlan Oral Liquid completed a randomized, double-blind, dose-seeking, multicenter Ⅱ phase A clinical trial on the safety and efficacy of acute upper respiratory tract infection in children

Fufangqinlan Oral Liquid

ZBD1042 (HNC042) completed phase I clinical trial and obtained trial summary report; The results showed good safety tolerability and supported further study

ZBD1042（HNC042)

ZBD Pharmaceutical“takes scientific and technoligical innovation as its care strategy and quality as the foundation of strategy”Gradually founds the R&D system with five basal research institutes and one management research center. With a range of modulations in reaserch mode including technical imitation, out-sourcing and self-innovate and global registration, corporate business will steady transformed from generics to branded drug or high-end drug and international development will be accelerated. Adhering the reasonable layout of sufficient plan, ZBD Pharmaceutical will devote its entire efforts to be the first-class technological and global innovative Blockbuster enterprises.

SERVICE

Technology platform

Is have 5 research instidutes in Beijing, Harbin and Shanghai, which serve as the basis for national-level post-doctoral research workstations, provincial enterprise technology centers, the key laboratory of Chinese medicine preparation technology and other platforms. Through the establishment of a professional R&D team, with the goal of building a high-precision drug R&D platform, ZBD clarifies the key R&D direction of chemical drugs and traditional Chinese medicine, and establishes a complete scientific and advanced R&D system.

Clinical Department

Clinical research departments are responsible for setting up the quality management system in line with GCP, guiding the strategy, formulating the development project for products, designing and implementing the clinical trials or BE studies for branded drugs, Conducting the supervision of clinical trials with stringent specification, which ensure the quality and efficiency, Following up the related medical progress of any products and Providing overall medical academic supports for company.

R&D Base

Founding the R&D system with five basal research institutes and one management research center, including Beijing Institute of Pharmaceutical Sciences, Harbin Institute of Pharmaceutical Sciences, Bozhou Institute of Traditional Chinese Medicine, Hangzhou Institute of Biological Pharmaceutical Sciences and Overseas Pharmaceutical Research Institute.